Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Melanomas that develop within the eye inhibit lymphocyte proliferation

D J Verbik1, T G Murray, J M Tran

  • 1The Schepens Eye Research Institute and Department of Ophthalmology, Harvard Medical School, Boston, MA 02114, USA. verbik@vision.eri.harvard.edu

International Journal of Cancer
|December 6, 1997
PubMed
Summary

Ocular melanoma cells are poor at stimulating T cells and actively inhibit their proliferation, unlike skin melanoma cells. This suggests the eye’s microenvironment alters melanoma immunogenicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Membrane-bound and soluble Fas ligands have opposite functions in photoreceptor cell death following separation from the retinal pigment epithelium.

Cell death & disease·2015
Same author

Intravitreal and subconjunctival melphalan for retinoblastoma in transgenic mice.

Journal of ophthalmology·2014
Same author

Lack of effect of SU1498, an inhibitor of vascular endothelial growth factor receptor-2, in a transgenic murine model of retinoblastoma.

The open ophthalmology journal·2009
Same author

Macular spectral-domain optical coherence tomography in patients with X linked retinoschisis.

The British journal of ophthalmology·2008
Same author

Increasing hyperopia and esotropia as the presenting signs of bilateral diffuse choroidal hemangiomas in a patient with Sturge-Weber syndrome.

Journal of pediatric ophthalmology and strabismus·2002
Same author

Corneal graft survival and intraocular pressure control after penetrating keratoplasty and glaucoma drainage device implantation.

Ophthalmology·2001

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • Melanoma, a significant skin cancer, can also arise in the eye.
  • Understanding the immune response to different melanoma types is crucial for treatment.

Purpose of the Study:

  • To compare the T-cell stimulating capacity of ocular versus skin melanoma cells.
  • To investigate the mechanisms behind any observed differences in immunogenicity.

Main Methods:

  • Mixed-lymphocyte tumor cell cultures using patient-derived melanoma cell lines.
  • Flow cytometry to assess HLA class I and II expression.
  • T-cell proliferation assays to evaluate stimulation and inhibition.

Main Results:

  • Skin melanoma cells robustly stimulated T-cell proliferation.

Related Experiment Videos

  • Ocular melanoma cells failed to stimulate T cells, even with IFN-gamma treatment.
  • Ocular melanoma cells actively inhibited T-cell proliferation via cell-to-cell contact.
  • This inhibitory function was lost in metastatic ocular melanoma cells.

    • Conclusions:

    • Ocular and skin melanomas exhibit distinct immunogenic properties.
    • Ocular melanomas are poorly immunogenic and suppress T-cell responses.
    • The ocular microenvironment appears to alter melanoma cell immunogenicity.